Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure

View through CrossRef
To assess the effect of oral digoxin on left ventricular systolic function in elderly patients, radionuclide angiography was performed on 20 patients 74 years old or older before and after several weeks of oral digoxin. The mean age was 83.8 years. All had congestive heart failure or cardiomegaly, and all were in sinus rhythm. The ejection fraction was 0.36 ± 0.10 (mean ± SD) before digoxin; 0.45 ± 0.09 after digoxin ( P < 0.01). A comparison group that did not receive digoxin had no significant improvement in ejection fraction. In ten patients serial radionuclide angiograms were repeated after increasing serum digoxin concentrations. Six demonstrated maximal improvement in ejection fraction at serum digoxin concentrations of 0.4–1.0 ng/ml. It is concluded that oral digoxin improves left ventricular ejection fraction in elderly patients with congestive heart failure or cardiomegaly who are in sinus rhythm. Some of these patients achieve maximal improvement in ejection fraction at serum digoxin concentrations of less than 1.0 ng/ml.
Title: Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure
Description:
To assess the effect of oral digoxin on left ventricular systolic function in elderly patients, radionuclide angiography was performed on 20 patients 74 years old or older before and after several weeks of oral digoxin.
The mean age was 83.
8 years.
All had congestive heart failure or cardiomegaly, and all were in sinus rhythm.
The ejection fraction was 0.
36 ± 0.
10 (mean ± SD) before digoxin; 0.
45 ± 0.
09 after digoxin ( P < 0.
01).
A comparison group that did not receive digoxin had no significant improvement in ejection fraction.
In ten patients serial radionuclide angiograms were repeated after increasing serum digoxin concentrations.
Six demonstrated maximal improvement in ejection fraction at serum digoxin concentrations of 0.
4–1.
0 ng/ml.
It is concluded that oral digoxin improves left ventricular ejection fraction in elderly patients with congestive heart failure or cardiomegaly who are in sinus rhythm.
Some of these patients achieve maximal improvement in ejection fraction at serum digoxin concentrations of less than 1.
0 ng/ml.

Related Results

Clinical signs and symptoms of toxic serum digoxin levels in neonates
Clinical signs and symptoms of toxic serum digoxin levels in neonates
Digoxin is widely used in the treatment of congestive heart failure and some arrhythmias. Digoxin toxicity may occur easily because digoxin has a narrow therapeutic index. This ret...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Left Ventricular Function in Hospitalized Geriatric Patients
Left Ventricular Function in Hospitalized Geriatric Patients
ABSTRACT: Left ventricular ejection fraction was measured by gated wall motion in 62 patients, 75 years old or older, admitted to a Geriatric Acute Assessment War...
Comorbidities and sex differences in chronic heart failure of ischemic etiology
Comorbidities and sex differences in chronic heart failure of ischemic etiology
Abstract Background: Comorbidities and sex differences play a major role in chronic heart failure (CHF). However, it is unknown whether the prevalence of comorbidities diff...
Efficacy of SGLT2 Inhibitors in Heart Failure to Improve Ejection Fraction
Efficacy of SGLT2 Inhibitors in Heart Failure to Improve Ejection Fraction
Background: Heart failure with reduced ejection fraction is a major cause of morbidity, hospital admission, and cardiovascular mortality worldwide. Many patients end up with poor f...
ASSA13-13-6 Clinical Study of Prenatal Trans-Placental Digoxin Therapy For Fetal Heart Failure
ASSA13-13-6 Clinical Study of Prenatal Trans-Placental Digoxin Therapy For Fetal Heart Failure
Objective Study the clinical efficacy and safety of transplacental digoxin therapy for foetal heart failure. Investigate the evaluation and treatment guiding valu...
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
Background: Digoxin is extensively prescribed for cardiac diseases, so its chronic or acute toxicity commonly occur. Although digoxin specific antibodies (anti-digoxin Fab) are rec...
Radioimmunoassay of Digoxin—Interference by Digitoxin
Radioimmunoassay of Digoxin—Interference by Digitoxin
Abstract Digitoxin interference with radioimmunoassay of digoxin may present a problem in determining digoxin concentrations in the serum of patients treated with di...

Back to Top